Cargando…

Duchenne's muscular dystrophy involves a defective transsulfuration pathway activity

Duchenne muscular dystrophy (DMD) is the most frequent X chromosome-linked disease caused by mutations in the gene encoding for dystrophin, leading to progressive and unstoppable degeneration of skeletal muscle tissues. Despite recent advances in the understanding of the molecular processes involved...

Descripción completa

Detalles Bibliográficos
Autores principales: Panza, E., Vellecco, V., Iannotti, F.A., Paris, D., Manzo, O.L., Smimmo, M., Mitilini, N., Boscaino, A., de Dominicis, G., Bucci, M., Di Lorenzo, A., Cirino, G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8246642/
https://www.ncbi.nlm.nih.gov/pubmed/34174560
http://dx.doi.org/10.1016/j.redox.2021.102040
_version_ 1783716353037828096
author Panza, E.
Vellecco, V.
Iannotti, F.A.
Paris, D.
Manzo, O.L.
Smimmo, M.
Mitilini, N.
Boscaino, A.
de Dominicis, G.
Bucci, M.
Di Lorenzo, A.
Cirino, G.
author_facet Panza, E.
Vellecco, V.
Iannotti, F.A.
Paris, D.
Manzo, O.L.
Smimmo, M.
Mitilini, N.
Boscaino, A.
de Dominicis, G.
Bucci, M.
Di Lorenzo, A.
Cirino, G.
author_sort Panza, E.
collection PubMed
description Duchenne muscular dystrophy (DMD) is the most frequent X chromosome-linked disease caused by mutations in the gene encoding for dystrophin, leading to progressive and unstoppable degeneration of skeletal muscle tissues. Despite recent advances in the understanding of the molecular processes involved in the pathogenesis of DMD, there is still no cure. In this study, we aim at investigating the potential involvement of the transsulfuration pathway (TSP), and its by-end product namely hydrogen sulfide (H(2)S), in primary human myoblasts isolated from DMD donors and skeletal muscles of dystrophic (mdx) mice. In myoblasts of DMD donors, we demonstrate that the expression of key genes regulating the H(2)S production and TSP activity, including cystathionine γ lyase (CSE), cystathionine beta-synthase (CBS), 3 mercaptopyruvate sulfurtransferase (3-MST), cysteine dioxygenase (CDO), cysteine sulfonic acid decarboxylase (CSAD), glutathione synthase (GS) and γ -glutamylcysteine synthetase (γ-GCS) is reduced. Starting from these findings, using Nuclear Magnetic Resonance (NMR) and quantitative Polymerase Chain Reaction (qPCR) we show that the levels of TSP-related metabolites such as methionine, glycine, glutathione, glutamate and taurine, as well as the expression levels of the aforementioned TSP related genes, are significantly reduced in skeletal muscles of mdx mice compared to healthy controls, at both an early (7 weeks) and overt (17 weeks) stage of the disease. Importantly, the treatment with sodium hydrosulfide (NaHS), a commonly used H(2)S donor, fully recovers the impaired locomotor activity in both 7 and 17 old mdx mice. This is an effect attributable to the reduced expression of pro-inflammatory markers and restoration of autophagy in skeletal muscle tissues. In conclusion, our study uncovers a defective TSP pathway activity in DMD and highlights the role of H(2)S-donors for novel and safe adjuvant therapy to treat symptoms of DMD.
format Online
Article
Text
id pubmed-8246642
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-82466422021-07-06 Duchenne's muscular dystrophy involves a defective transsulfuration pathway activity Panza, E. Vellecco, V. Iannotti, F.A. Paris, D. Manzo, O.L. Smimmo, M. Mitilini, N. Boscaino, A. de Dominicis, G. Bucci, M. Di Lorenzo, A. Cirino, G. Redox Biol Research Paper Duchenne muscular dystrophy (DMD) is the most frequent X chromosome-linked disease caused by mutations in the gene encoding for dystrophin, leading to progressive and unstoppable degeneration of skeletal muscle tissues. Despite recent advances in the understanding of the molecular processes involved in the pathogenesis of DMD, there is still no cure. In this study, we aim at investigating the potential involvement of the transsulfuration pathway (TSP), and its by-end product namely hydrogen sulfide (H(2)S), in primary human myoblasts isolated from DMD donors and skeletal muscles of dystrophic (mdx) mice. In myoblasts of DMD donors, we demonstrate that the expression of key genes regulating the H(2)S production and TSP activity, including cystathionine γ lyase (CSE), cystathionine beta-synthase (CBS), 3 mercaptopyruvate sulfurtransferase (3-MST), cysteine dioxygenase (CDO), cysteine sulfonic acid decarboxylase (CSAD), glutathione synthase (GS) and γ -glutamylcysteine synthetase (γ-GCS) is reduced. Starting from these findings, using Nuclear Magnetic Resonance (NMR) and quantitative Polymerase Chain Reaction (qPCR) we show that the levels of TSP-related metabolites such as methionine, glycine, glutathione, glutamate and taurine, as well as the expression levels of the aforementioned TSP related genes, are significantly reduced in skeletal muscles of mdx mice compared to healthy controls, at both an early (7 weeks) and overt (17 weeks) stage of the disease. Importantly, the treatment with sodium hydrosulfide (NaHS), a commonly used H(2)S donor, fully recovers the impaired locomotor activity in both 7 and 17 old mdx mice. This is an effect attributable to the reduced expression of pro-inflammatory markers and restoration of autophagy in skeletal muscle tissues. In conclusion, our study uncovers a defective TSP pathway activity in DMD and highlights the role of H(2)S-donors for novel and safe adjuvant therapy to treat symptoms of DMD. Elsevier 2021-06-19 /pmc/articles/PMC8246642/ /pubmed/34174560 http://dx.doi.org/10.1016/j.redox.2021.102040 Text en © 2021 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Research Paper
Panza, E.
Vellecco, V.
Iannotti, F.A.
Paris, D.
Manzo, O.L.
Smimmo, M.
Mitilini, N.
Boscaino, A.
de Dominicis, G.
Bucci, M.
Di Lorenzo, A.
Cirino, G.
Duchenne's muscular dystrophy involves a defective transsulfuration pathway activity
title Duchenne's muscular dystrophy involves a defective transsulfuration pathway activity
title_full Duchenne's muscular dystrophy involves a defective transsulfuration pathway activity
title_fullStr Duchenne's muscular dystrophy involves a defective transsulfuration pathway activity
title_full_unstemmed Duchenne's muscular dystrophy involves a defective transsulfuration pathway activity
title_short Duchenne's muscular dystrophy involves a defective transsulfuration pathway activity
title_sort duchenne's muscular dystrophy involves a defective transsulfuration pathway activity
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8246642/
https://www.ncbi.nlm.nih.gov/pubmed/34174560
http://dx.doi.org/10.1016/j.redox.2021.102040
work_keys_str_mv AT panzae duchennesmusculardystrophyinvolvesadefectivetranssulfurationpathwayactivity
AT velleccov duchennesmusculardystrophyinvolvesadefectivetranssulfurationpathwayactivity
AT iannottifa duchennesmusculardystrophyinvolvesadefectivetranssulfurationpathwayactivity
AT parisd duchennesmusculardystrophyinvolvesadefectivetranssulfurationpathwayactivity
AT manzool duchennesmusculardystrophyinvolvesadefectivetranssulfurationpathwayactivity
AT smimmom duchennesmusculardystrophyinvolvesadefectivetranssulfurationpathwayactivity
AT mitilinin duchennesmusculardystrophyinvolvesadefectivetranssulfurationpathwayactivity
AT boscainoa duchennesmusculardystrophyinvolvesadefectivetranssulfurationpathwayactivity
AT dedominicisg duchennesmusculardystrophyinvolvesadefectivetranssulfurationpathwayactivity
AT buccim duchennesmusculardystrophyinvolvesadefectivetranssulfurationpathwayactivity
AT dilorenzoa duchennesmusculardystrophyinvolvesadefectivetranssulfurationpathwayactivity
AT cirinog duchennesmusculardystrophyinvolvesadefectivetranssulfurationpathwayactivity